MarketCap
Facebook
X
TelegramFluidigm Corporation Betriebsaufwand 2011-2025 | FLDM
Betriebsaufwand Jährlich Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 134 M | 116 M | 110 M | 110 M | 132 M | 122 M | 115 M | 68.4 M | 55.1 M | 45.2 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 134 M | 45.2 M | 101 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 18.68 | -3.56 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 20.26 | -6.03 % | $ 218 M |  China |
 |
Co-Diagnostics
CODX
|
45.3 M | $ 0.23 | -3.83 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 39.13 | -0.67 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 230.63 | 0.13 % | $ 169 B | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.51 | -0.66 % | $ 1.92 M | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 10.22 | 1.79 % | $ 290 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.55 | -0.02 % | $ 18.8 B | USA |
 |
DexCom
DXCM
|
1.69 B | $ 68.07 | 0.74 % | $ 26.3 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 26.58 | -0.52 % | $ 804 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
484 M | $ 19.2 | -1.41 % | $ 1.03 B | USA |
 |
Celcuity
CELC
|
113 M | $ 100.79 | -1.43 % | $ 3.98 B | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 3.15 | -1.56 % | $ 100 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 226.62 | -0.13 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
226 M | $ 102.07 | -0.88 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
709 M | $ 6.4 | -1.23 % | $ 580 M | USA |
 |
ENDRA Life Sciences
NDRA
|
10.8 M | $ 4.92 | -1.4 % | $ 2.64 M | USA |
 |
Neogen Corporation
NEOG
|
1.48 B | $ 7.27 | 1.94 % | $ 1.58 B | USA |
 |
Illumina
ILMN
|
3.69 B | $ 134.24 | -0.53 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 202.71 | -0.41 % | $ 10.4 B | USA |
 |
National Research Corporation
NRC
|
38.5 M | $ 18.43 | -1.23 % | $ 452 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 175.51 | -0.26 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
106 M | $ 6.65 | -2.57 % | $ 862 M | USA |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 253.42 | -0.21 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 182.22 | -0.34 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.25 B | $ 685.3 | -0.46 % | $ 56.5 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 67.03 | 0.48 % | $ 4.64 B | USA |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 413.45 | -0.48 % | $ 30 B |  Schweiz |
 |
Agilent Technologies
A
|
1.99 B | $ 138.24 | -0.11 % | $ 42 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.33 | 0.83 % | $ 20 B |  Niderland |
 |
Biomerica
BMRA
|
5.64 M | $ 2.7 | - | $ 6.2 M | USA |
 |
Bioventus
BVS
|
217 M | $ 7.47 | 0.13 % | $ 468 M | USA |
 |
Personalis
PSNL
|
44.5 M | $ 8.13 | -0.12 % | $ 482 M | USA |